|Bid||45.28 x 900|
|Ask||45.29 x 800|
|Day's range||44.94 - 45.48|
|52-week range||39.30 - 57.88|
|Beta (5Y monthly)||0.49|
|PE ratio (TTM)||N/A|
|Earnings date||29 Apr 2020|
|Forward dividend & yield||3.36 (7.44%)|
|Ex-dividend date||23 Dec 2019|
|1y target est||55.11|
Altria Presents at the Consumer Analyst Group of New York Conference; Reaffirms Full-year 2020 Earnings Guidance
Convertible notes are not just for early-stage startups any more. Convertible notes allow companies more time to develop their businesses before deciding who gets what. In recent months, however, more established companies that have already raised priced rounds have raised money via convertible notes.
Investing.com - Vaping company Juul Labs has raised a more funds for its operations at a time when the sector is getting hit hard by new regulations, The Wall Street Journal reported Thursday.
The Marlboro maker in the United States said on Thursday the fourth-quarter charge was mainly due to the increased number of legal cases pending against Juul and the expectation that the number would continue to grow. Overall, Altria has recorded $8.6 billion in impairment charges after it took a 35% stake in Juul for $12.8 billion in December 2018. "I'm highly disappointed in the financial performance of the Juul investment," Altria Chief Executive Officer Howard Willard said on a post-earnings call.
Lawsuits on behalf of young consumers have targeted leading e-cigarette maker Juul Labs Inc. Altria, which holds a stake in Juul, said the number of cases pending against the e-cigarette maker has surged by more than 80% since October. Several states have instituted partial or total bans on vaping devices, and retailers and industry groups have challenged those bans in courts. The lawsuits target Juul, which markets a nicotine-vaping device and controls about 75% of the e-cigarette market.
Altria's (MO) fourth-quarter 2019 results reflect gains from strong pricing. Revenues improve in the smokeless products unit but decline in the smokeable products unit.
Altria (MO) delivered earnings and revenue surprises of 0.99% and -1.94%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
The company that makes Marlboro cigarettes saw in late 2018 the opportunity to offset declining tobacco sales with a $13 billion investment in Juul, the e-cigarette maker. Since October, the company said the number of legal cases against Juul have spiked 80%.
Altria Reports 2019 Fourth-Quarter and Full-Year Results
Investing.com - Altria reported on Thursday fourth quarter earnings that matched analysts' forecasts and revenue that fell short of expectations.
Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Coca-Cola's (KO) fourth-quarter 2019 results are likely to reflect benefits from its innovation efforts, product investments, strength across regions, and robust price/mix and volume.
McCormick's (MKC) fourth-quarter fiscal 2019 results are likely to reflect gains from innovation and savings from the CCI program. However, volatile currency movements are concerning.
Altria Group is showing signs of buyer's remorse when it comes to the 35 percent stake it bought in e-cigarette company Juul. Altria, the parent company of old-school cigarette brands like Marlboro, said Thursday that it will stop providing services including logistics, distribution and access to retail shelf space to Juul. A string of vaping-related deaths- though none connected to Juul- coupled with a growing number of government bans on e-cigarettes after a surge in teen vaping, has clouded what once was a very promising future for Juul and a new smoking category that was supposed to offset the decline in traditional cigarettes. Altria is watching the value of its investment go up in smoke. On Thursday, Altria announced a $4 billion write-down on its Juul investment in the fourth quarter mainly due to the growing number of legal cases facing the e-vaping company, that brings Altria's total write-down to nearly $9 billion. It only paid $12.8 billion for the Juul stake back in December 2018. With that in mind, Altria has now re-worked the terms of the deal - taking a step back to only help Juul with regulatory affairs including the submission of products for FDA approval. But Altria isn't optimistic about the future - on Thursday's earnings conference call, the CEO said he expected to see a continued slowdown or outright decline in the e-vaping category and said there was always the chance Juul could get pulled off the market by federal law. Juul's problems helped swing Altria from a fourth-quarter profit to a loss of nearly $2 billion. Shares of Altria were down in Thursday trade.